Related Experiment Videos
Differences in human cell lines to support stable replication of Epstein-Barr virus-based vectors
M Vidal1, C Wrighton, S Eccles
1Laboratory of Gene Structure and Expression, National Institute for Medical Research, Mill Hill, London, U.K.
Biochimica Et Biophysica Acta
|April 6, 1990
Summary
Epstein-Barr virus (EBV) vectors behave differently in human cells. Over-expression of EBV nuclear antigen 1 (EBNA-1) from these vectors can harm cell growth, impacting their use in research.
Area of Science:
- Molecular Biology
- Virology
- Cell Biology
Background:
- Epstein-Barr virus (EBV) vectors utilize the ori-P replication origin and EBNA-1 protein for extrachromosomal maintenance in human cells.
- Understanding EBV vector behavior is crucial for gene delivery and episomal maintenance applications.
Purpose of the Study:
- To investigate the differential behavior of two EBV vectors (p201 and p292) in distinct human cell lines (A431 and HeLa).
- To assess the impact of EBNA-1 expression levels on vector episomal stability and cell viability.
Main Methods:
- Transfection of A431 and HeLa cells with EBV vectors p201 and p292.
- Analysis of vector transfectability, episomal integrity, and chromosomal integration.
- Evaluation of EBNA-1 gene expression and its effect on cell growth.
Main Results:
- HeLa cells showed high transfectability with both vectors, maintaining episomal forms.
- A431 cells were efficiently transfected only by p292, exhibiting significant chromosomal integrations and rearrangements.
- Higher EBNA-1 expression from p292 correlated with detrimental effects on the growth of both cell lines.
Conclusions:
- EBV vector performance is cell line-dependent.
- Over-expression of EBNA-1 from EBV vectors can be cytotoxic, potentially limiting their therapeutic or research applications.
- Careful selection of EBV vectors and cell lines is necessary for successful episomal vector-based studies.